You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 54879-0001


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 54879-0001

Drug NameNDCPrice/Unit ($)UnitDate
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.32477 EACH 2025-04-23
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.32241 EACH 2025-03-19
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.31142 EACH 2025-02-19
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.30768 EACH 2025-01-22
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.30028 EACH 2024-12-18
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.30994 EACH 2024-11-20
ETHAMBUTOL HCL 100 MG TABLET 54879-0001-01 0.29461 EACH 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 54879-0001

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 54879-0001

Understanding the NDC Directory

To analyze the market and project prices for a specific drug, it is crucial to start with the National Drug Code (NDC) Directory maintained by the FDA. The NDC Directory contains comprehensive information on finished, unfinished, and compounded drug products, including their marketing start and end dates, labeler information, and other critical details[1][4].

Identifying the Drug

The NDC code 54879-0001 can be looked up in the FDA's NDC Directory to identify the specific drug product. This directory provides details such as the proprietary name, non-proprietary name, dosage form, route of administration, and the labeler name. For example, if we search by the NDC number, the directory will populate the relevant product information[4].

Current Market Trends

Prescription Drug Price Increases

Recent trends indicate that prescription drug prices have been increasing significantly. From January 2022 to January 2023, more than 4,200 drug products saw price increases, with 46% of these increases exceeding the rate of inflation. The average price increase during this period was 15.2%, translating to $590 per drug product[2].

Impact on Affordability

High prescription drug prices pose significant affordability challenges for patients, healthcare payers, employers, and taxpayers. The frequent and substantial price increases add to these challenges, making it essential to monitor and predict future price changes[2].

Price Projections for 2025

Overall Drug Price Inflation

According to the Vizient Pharmacy Market Outlook for Summer 2024, the projected overall drug price inflation rate for January 1, 2025, to December 31, 2025, is expected to be around 0.00%. However, this projection is general and may not reflect the specific dynamics of the drug with NDC 54879-0001[3].

Gene Therapy and Advanced Treatments

The increasing approval and use of gene therapies and other advanced treatments highlight the potential for significant price increases in specific segments of the pharmaceutical market. For instance, a recently approved gene therapy for a rare neurological disorder costs $4.25 million, underscoring the escalating costs of advanced treatments[3].

Factors Influencing Price Changes

List Price Increases

List prices of prescription drugs can change at any time after launch. The frequency and magnitude of these changes vary, with the largest number of price increases typically occurring in January and July each year. The average price increase for single-source drugs tends to be lower in percentage terms but higher in absolute dollar values compared to multi-source drugs[2].

Medicare Drug Price Negotiation

Beginning in January 2026, Medicare will implement negotiated prices for certain high-cost drugs, including those with significant list price increases over the years. For example, nine out of the ten drugs selected for the first year of negotiation saw list price increases ranging from 20% to 55% between 2018 and 2023. These negotiations result in discounts ranging from 38% to 79% compared to list prices[5].

Specific Price Projections for NDC 54879-0001

To make accurate price projections for the drug with NDC 54879-0001, one would need to:

  1. Identify the Drug: Determine the proprietary and non-proprietary names, dosage form, and labeler.
  2. Historical Price Trends: Analyze past price changes for this specific drug using the NDC Directory and other sources.
  3. Market Conditions: Consider the overall market trends, including inflation rates and regulatory changes.
  4. Competitive Landscape: Evaluate the presence of multi-source or single-source competitors and their pricing strategies.

Example Analysis

If the drug with NDC 54879-0001 is a single-source drug, it might experience a lower percentage price increase but a higher absolute dollar increase compared to multi-source drugs. Here is a hypothetical example:

  • Historical Data: If the drug had a list price of $100 per unit in 2022 and increased by 7.4% (the average for single-source drugs) in 2023, it would reach $107.40.
  • Projected Increase: Assuming a similar trend in 2025, with an average increase of around 7%, the price could rise to approximately $114.90.

Key Takeaways

  • NDC Directory: Essential for identifying and tracking drug products.
  • Price Trends: Prescription drug prices are increasing, with significant variations between single-source and multi-source drugs.
  • Regulatory Changes: Medicare's drug price negotiation program will impact certain high-cost drugs starting in 2026.
  • Market Projections: Specific price projections require detailed historical data and market analysis.

FAQs

  1. What is the NDC Directory?

    • The NDC Directory is a database maintained by the FDA that contains information on finished, unfinished, and compounded drug products, including their marketing start and end dates and other critical details[1].
  2. How often do prescription drug prices change?

    • Prescription drug prices can change at any time after launch, with the largest number of changes typically occurring in January and July each year[2].
  3. What is the impact of Medicare's drug price negotiation program?

    • The program will result in negotiated prices for certain high-cost drugs, offering discounts ranging from 38% to 79% compared to list prices starting in January 2026[5].
  4. How do single-source and multi-source drugs differ in terms of price increases?

    • Single-source drugs tend to have lower percentage price increases but higher absolute dollar increases, while multi-source drugs have higher percentage increases but lower absolute dollar increases[2].
  5. What are the projected overall drug price inflation rates for 2025?

    • According to the Vizient Pharmacy Market Outlook, the projected overall drug price inflation rate for 2025 is expected to be around 0.00%[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE
  3. Pharmacy Market Outlook Summer 2024 - Vizient Inc.
  4. NDC Directory (March 2015) - FDA
  5. Medicare Drug Price Negotiation Program - ASPE, HHS.gov

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.